Industry averages
Pharmaceuticals & Biotechnology
Five-year financial averages across all companies in this industry classification. Figures computed from Wright Investors' Service data and expressed as per-company averages.
Data notes
- Averages exclude zero-value company years
- All monetary figures in USD Billions
- Company count shows coverage per year
- Derived from income statement and balance sheet data
Income Statement Averages
Per-company averages · USD Billions
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Sales / Revenue | 88 | 92 | 95 | 101 | 108 | 7 |
| Cost of Goods Sold | 56 | 59 | 61 | 65 | 69 | 4 |
| SG&A Expenses | 24 | 26 | 27 | 28 | 30 | 3 |
| EBITDA | 14 | 14 | 12 | 14 | 17 | 1 |
| Net Income | 8 | 7 | 5 | 7 | 8 | -0 |
| Earnings Per Share | -170,390.36 | -1,660.75 | -162.92 | 63.68 | 88.13 | 102.42 |
Balance Sheet Averages
Per-company averages · USD Billions
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Cash & Short-Term Investments | 28 | 28 | 24 | 24 | 25 | 2 |
| Total Current Assets | 67 | 73 | 71 | 74 | 78 | 6 |
| Total Assets | 133 | 146 | 155 | 164 | 175 | 25 |
| Total Liabilities | 49 | 54 | 56 | 62 | 68 | 7 |
| Long-Term Debt | 14 | 13 | 12 | 18 | 20 | 2 |
| Common Equity | 78 | 83 | 92 | 94 | 99 | 18 |
Industry report catalogue
Browse available PDF report editions by sector and region or country.
ResearchCompany research
Drill into individual company financials in the same industry.
ScreeningScreen by industry
Filter the full company universe by this industry classification.